NEW YORK (TheStreet) -- CHANGE IN RATINGS
Advisory Board was intitiated with a buy rating at Bank of America/Merrill Lynch. $67 price target. Company can deliver solid growth and deserves a premium valuation.
Aetna was upgraded at Bank of America/Merrill Lynch to buy from neutral. Valuation call, based on a $79 price target, BofA/Merrill said.
Axiall was downgraded at BofA/Merrill to neutral from buy. $45 price target. Company lacks near-term catalysts, BofA/Merrill said.
Brady was downgraded at Robert Baird to neutral from outperform. $33 price target. WPS segment will likely grow faster than expected, Robert Baird said.
Dominion Resources was upgraded at J.P. Morgan to overweight from neutral. $68 price target. Midstream growth and the formation of an MLP next year will unlock value from the existing assets, J.P. Morgan said.
Finish Line was upgraded at Piper Jaffray to neutral from underweight. $21 price target. Comps are easing and the Macy's initiative will likely be positive, Piper Jaffray said.
Intel was upgraded at Jefferies to buy from hold. $30 price target. Focusing its manufacturing leadership to make MPUs that are lower power, higher performance and cheaper, Jefferies said.
NTELOS was downgraded to hold at TheStreet Ratings.
Pinnacle West Capital was upgraded to neutral from sell at Citigroup. A key overhang related to the deregulation of the retail electric market in Arizona was removed, said Citigroup. Price target is $57.
QEP Resources was downgraded at Deutsche Bank to hold. $34 price target. Valuation call, as the stock has outperformed its peers by 28% year to date, Deutsche Bank said.
Teva Pharmaceuticals was downgraded at J.P. Morgan to neutral from overweight. $43 price target. Recovery is likely to be a gradual one with need to rebuild pipeline in the face of an eroding Copaxone franchise, J.P. Morgan said.
Under Armour was downgraded at DA Davidson to neutral from buy. $85 price target. Valuation call, as the stock is up 65% year-to-date, DA Davidson said.
Urban Outfitters was initiated with a buy rating at Sterne Agee. $45 price target. Bar has been reset and the company offers a compelling growth story, Sterne Agee said.
Vitamin Shoppe was downgraded at Sterne Agee to neutral. $45 price target. Traffic and pricing have stalled, Sterne Agee said.
Wellpoint was upgraded at Bank of America/Merrill Lynch to neutral. $98 price target. Exchanges will likely be less disruptive to business, BofA/Merrill said.
Wipro was upgraded to buy at TheStreet Ratings.
STOCK COMMENTS / EPS CHANGES
Apple numbers were cut at Jefferies. Shares are now seen reaching $425. Estimates were also lowered on disappointing iPhone 5C and channel checks, Jefferies said. Hold rating.
Baidu numbers were raised at Jefferies. Shares are now seen reaching $153. Estimates were also increased on better-than-expected mobile search monetization, Jefferies said. Hold rating.
Jazz numbers were raised at UBS. Estimates and price target were raised given a minor adjustment to the pipeline, said UBS. Price target was bumped up to $98.
Kroger numbers were raised at UBS. Earnings estimates were raised to reflect guidance and market share gains, said UBS. Price target was increased to $38.
Plexus numbers were increased at Citigroup. Earnings estimates were raised to reflect higher internal margins, Citi said. Price target is raised to $38.
>To submit a news tip, email: firstname.lastname@example.org.
Follow TheStreet on Twitter and become a fan on Facebook.
EXCLUSIVE OFFER: See inside Jim Cramer’s multi-million dollar charitable trust portfolio to see the stocks he thinks could be potentially HUGE winners. Click here to see his holdings for FREE.
- Investment & Company Information